FRTY Overview

• Launch of Alger Russell Innovation ETF: Alger has introduced the Alger Russell Innovation ETF (INVN) with an expense ratio of 0.55%, focusing on innovative companies with high potential, investing at least 80% of its assets in securities from the Alger Russell Innovation Index.

• Investment Strategy and Holdings: The fund's portfolio includes around 50 holdings, with top investments in BioMarin Pharmaceutical, Teradata Corporation, and Bristol-Myers Squibb, utilizing a quantitative methodology to select and rank innovation-driven equities based on research and development expenditures.

• Market Sentiment and Economic Outlook: The U.S. economy shows improving market sentiments despite concerns over the presidential election, Fed rate cuts, and geopolitical tensions affecting oil prices, which have sparked inflation fears. However, earnings estimates for large-cap stocks have declined, indicating potential risks ahead.

• Mid-Cap Stocks Performance: Mid-cap exchange-traded funds (ETFs) have performed well recently, with notable gains in several ETFs, suggesting they may offer a balanced investment opportunity amidst uncertainties affecting large-cap stocks due to their foreign exposure and economic conditions.

Stifel analyst upgraded Saia, Inc. to Buy from Hold, reducing the price target to $475 from $526.

Despite execution risks, the analyst sees Saia as a well-run carrier with strong market share growth prospects and improving pricing power.